20083 ⎘
Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles; Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction; Excipients; Inactive ingredients; Organic compounds, e.g. phospholipids, fats Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
#902NANOPARTICULATE FORMULATION COMPRISING A mPGES-1 INHIBITOR
#903Ternary mixture formulations
#904HIGHLY CONCENTRATED DRUG PARTICLES, FORMULATIONS, SUSPENSIONS AND USES THEREOF
#905Solid oral dosage form of lipophilic compounds
#906PHARMACEUTICAL COMPOSITIONS FOR TRANSMUCOSAL DELIVERY
#907Vaccination compositions, methods of making, and methods of use
#908Lyophilized pharmaceutical composition of Fc-peptide fusion protein
#909Controlled release delivery device comprising an organosol coat
#910Pharmaceutical Compositions Comprising Levocetirizine
#911Use of polyols to obtain stable polymorphous forms of rifaximin
#912Pharmaceutical compositions
#913Pharmaceutical composition and administrations thereof
#914DRY POWDER FORMULATION OF AZOLE DERIVATIVE FOR INHALATION
#915Compositions and methods for atmospheric spray freeze drying
#916Crystalline freebase forms of a biphenyl compound
#917Osmotic delivery device comprising an insulinotropic peptide and uses thereof
#918Alfentanil composition for the treatment of acute pain
#919Thymic stromal lymphopoietin (TSLP)-binding molecules and methods of using the molecules
#920Stable multiparticulate pharmaceutical composition of rosuvastatin
#921Cannabinoid compositions and uses
#922Formulation of fat-soluble vitamin
#923Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins
#924FILM DELIVERY SYSTEM FOR ACTIVE INGREDIENTS
#925Method and system for producing high purity vancomycin hydrochloride
#926SOLID NANOPARTICLE FORMULATION OF MICROTUBLE INHIBITORS WITH REDUCED OSTWALD REPENING FOR ORAL ADMINISTRATION
#927Hybrid anticancer prodrug simultaneously producing cinnamaldehyde and quinone methide and method for preparing same
#928Formula of neuregulin preparation
#929Triptan powders for pulmonary delivery
#930Encapsulated active ingredients for controlled enteric release
#931Compositions and methods for transplantation of colon microbiota
#932Lanthanum carbonate compositions
#933Complex granule formulation having improved stability comprising levocetirizine and montelukast
#934Methods for the preparation of liposomes
#935NOVEL PROCESS FOR PRODUCING TRANSMUCOSAL PHARMACEUTICAL FORMULATIONS AND FORMULATIONS THUS OBTAINED
#936Orally disintegrating compositions
#937SUSTAINED RELEASE FORMULATIONS USING NON-AQUEOUS CARRIERS
#938Synthetic peptide that increases radiosensitivity of tumor cells and use of same
#939Compositions and methods for treating hyperkalemia
#940Method of drug formulation
#941Pediatric oral suspension formulations of amoxicillin and clavulanate potassium and method for using same
#942Process for producing a preparation in powder form containing at least one carotenoid
#943Compositions for fecal floral transplantation and methods for making and using them and device for delivering them
#944Aerosol formulations of granisetron and uses thereof
#945Orodispersible mannitol
#946PROCESS FOR PRODUCTION OF BIVALIRUDIN
#947Microparticle formulations for delivery to the lower and central respiratory tract and methods of manufacture
#948Pharmaceutical composition containing clomipramine and preparation method therefor
#949Aerosol formulations of ondansetron and uses thereof
#950Dialkyl sulfosuccinate compositions, method of making, and method of use
#951Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
#952Orally disintegrating solid dosage unit containing an estetrol component
#953Bendamustine solid dispersions and continuous infusion
#954Capsule containing total flavonoids of desmodium styracifolium, method for preparing the same and use
#955Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infections
#956Dihydroorotic and acid dehydrogenase inhibitor
#957Formulations of 6-mercaptopurine
#958Storage stable lyophilized tripeptide formulations
#959Compositions and methods for transplantation of colon microbiota
#960Sodium diacetate crystal and solid dialysis preparation comprising said crystal
#961Use of stabilized granules containing glyceryl trinitrate for arteriogenesis
#962Formulations of single domain antigen binding molecules
#963STABLE POWDER FORMULATION CONTAINING AN ANTICHOLINGERIC AGENT
#964Osmotic drug delivery system
#965COMPOSITE FORMULATION COMPRISING TADALAFIL AND AMLODIPINE
#966MANUFACTURE OF A PHARMACEUTICAL PRODUCT
#967Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride
#968Process for the preparation of a freeze-dried pharmaceutical composition containing mitomycin C
#969Rapidly dispersible dosage form of oxcarbazepine
#970DRY POWDER INHALER
#971Preparation in the form of a powder containing at least one carotenoid, at least one modified starch, and sucrose
#972Method, composition and package for bowel cleansing
#973HYALURONIC ACID FORMULATION
#974Modified release compositions comprising tacrolimus
#975Treatment using dantrolene
#976Method Of Making Particles For Use In A Pharmaceutical Composition
#977METHOD FOR PRODUCING SWEETENER COMPOSITIONS AND SWEETENER COMPOSITIONS
#978KDM1A inhibitors for the treatment of disease
#979Process for stabilizing an adjuvant containing vaccine composition
#980Sugar ester nanoparticle stabilizers
#981Process for preparing a medicament
#982Rapamycin for the treatment of lymphangioleiomyomatosis
#983METHOD AND APPARATUS FOR MAKING COMPOSITIONS FOR PULMONARY ADMINISTRATION
#984Reduction of flake-like aggregation in nanoparticulate active agent compositions
#985Reduction of flake-like aggregation in nanoparticulate active agent compositions
#986Reduction of flake-like aggregation in nanoparticulate active agent compositions
#987STABLE SOLID UNITS AND METHODS OF MAKING THE SAME
#988Selective production method for D-mannitol α-form crystal using spray-drying method
#989Dry formulations of vaccines that are room temperature stable
#990Biphenyl compounds useful as muscarinic receptor antagonists
#991Vaccine formulation
#99217-hydroxyprogesterone ester-containing oral compositions and related methods
#993Method for treating intestinal fibrosis
#994Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
#995Pharmaceutical Composition Comprising Temozolomide With Improved Stability and Process for Manufacturing the Same
#996Solid dispersions comprising tacrolimus
#997Pharmaceutical compositions and related methods of delivery
#998Heat-stable dry powder pharmaceutical compositions and methods
#999Manufacture of Pharmaceutical Compositions
#1000Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
#1001Crystalline freebase forms of a biphenyl compound
#1002PHARMACEUTICAL COMPOSITIONS OF FINGOLIMOD
#1003Pazopanib formulation
#1004Compositions for multiphase, staggered, or sustained release of an active substance
#1005Formulation of meloxicam
#1006Dry powder vancomycin compositions and associated methods
#1007Pharmaceutical composition containing budesonide and formoterol
#1008Treatment using dantrolene
#1009Oral pharmaceutical dosage forms
#1010Use of pidotimod to treat irritable bowel syndrome
#1011Granulate for the formulation of orodispersible tablets
#1012Composition comprising at least two dry powders obtained by spray drying to increase the stability of the formulation
#1013Immunogenic composition
#1014Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
#1015Compositions and methods of using (R)-pramipexole
#1016Osmotic drug delivery system
#1017Stabilization of moisture-sensitive drugs
#1018Compounds to modulate intestinal absorption of nutrients
#1019ENCAPSULATED COMPOSITION FOR BINDING ALDEHYDES IN THE STOMACH
#1020HIGHLY CONCENTRATED DRUG PARTICLES, FORMULATIONS, SUSPENSIONS AND USES THEREOF
#1021POWDER FORMULATION COMPRISING THROMBIN AND FIBRINOGEN
#1022Crystalline microspheres and the process of manufacturing the same
#1023CURCUMIN SOLID LIPID PARTICLES AND METHODS FOR THEIR PREPARATION AND USE
#1024Stabilized granules containing glyceryl trinitrate
#1025Formulations of guanylate cyclase C agonists and methods of use
#1026Rapidly dispersible dosage form of oxcarbazepine
#1027Spray dried compositions having different dissolution profiles and processes for their preparation
#1028Crystallized oxalate decarboxylase and methods of use
#1029Pharmaceutical composition for treating headache, and preparation method thereof
#1030Formulation of meloxicam
#1031Microgranular formulation including coagulation unit comprising discontinuous phase and continuous phase
#1032Pharmaceutical compositions for gastrointestinal drug delivery
#1033Multiparticles safeguarded against ethanolic dose-dumping
#1034Orodispersible tablets obtained by compression molding
#1035Composition
#103617-hydroxyprogesterone ester-containing oral compositions and related methods
#1037Pharmaceutical core-shell composite powder and processes for making the same
#1038PROCESS FOR MAKING AGGLOMERATES USING ACOUSTIC MIXING TECHNOLOGY
#1039Formulations of 6-mercaptopurine
#1040Method for producing sweetener compositions and sweetener compositions
#1041Orally disintegrating tablets and methods of manufacture
#1042Nicotine Formulations and Methods of Making the Same
#1043Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment
#1044Pouch containing nicotine in free salt form
#1045ORAL PREPARATION AND METHOD FOR PRODUCING THE SAME
#1046Composition for the prophylaxis of candidiasis
#1047Oral dosage forms of bendamustine and therapeutic use thereof
#1048Bendamustine solid dispersions and continuous infusion
#1049MODIFIED AND IMMEDIATE RELEASE FORMULATIONS OF MEMANTINE
#1050NOVEL POWDERED CRYSTALLINE MEDICINES FOR INHALATION
#1051Solid composition comprising iron for use in iron deficient conditions
#1052Spray drying vancomycin
#1053TIOTROPIUM PREPARATIONS
#1054Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery
#1055Preparation of desiccated liposomes for use in compressible delivery systems
#1056Escalating Dosing Regimen for Effecting Weight Loss and Treating Obesity
#1057Pharmaceutical or nutraceutical composition with sustained release characteristic and with resistance against the influence of ethanol
#1058COMPOSITIONS COMPRISING MUSCARINIC RECEPTOR ANTAGONIST AND GLUCOSE ANHYDROUS
#105917-Hydroxyprogesterone ester containing oral compositions and related methods
#1060Efficient aqueous encapsulation and controlled release of bioactive agents
#1061Inhalation compositions comprising muscarinic receptor antagonist
#1062Method for producing matrix-type pharmaceutical solid preparation
#1063Palatable oral veterinary compositions
#1064Formulations and methods for lyophilization and lyophilates provided thereby
#1065Manufacture of degarelix
#1066CRYSTALLINE MICROSPHERES AND THE PROCESS FOR MANUFACTURING THE SAME
#1067Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infections
#1068Alfentanil composition for the treatment of acute pain
#1069VACCINE FORMULATION OF MANNOSE COATED PEPTIDE PARTICLES
#1070Nanocrystalline solid dispersion compositions and process of preparation thereof
#1071Devices, formulations, and methods for delivery of multiple beneficial agents
#1072PHARMACEUTICAL COMPOSITION OF ENTECAVIR AND PROCESS OF MANUFACTURING
#1073Process for obtaining a modafinil-based pharmaceutical composition, resulting pharmaceutical composition and use thereof
#1074AGGREGATE NANOPARTICULATE MEDICAMENT FORMULATIONS, MANUFACTURE AND USE THEREOF
#1075Stabilized formulations of CNS compounds
#1076ANTIRETROVIRAL COMPOSITION
#1077Aggregate particles
#1078USE OF POLYOLS TO OBTAIN STABLE POLYMORPHOUS FORMS OF RIFAXMIN
#1079Abuse resistant forms of immediate release oxymorphone, method of use and method of making
#1080Abuse resistant forms of extended release hydrocodone, method of use and method of making
#1081Bendamustine pharmaceutical compositions
#1082Anti-fatigue composition, formulation and use thereof
#1083Diclofenac formulations and methods of use
#1084Abuse resistant forms of extended release oxymorphone, method of use and method of making
#1085Abuse resistant forms of immediate release hydromorphone, method of use and method of making
#1086Pharmaceutical dosage forms comprising valganciclovir hydrochloride
#1087Film-coated and/or granulated calcium-containing compounds and use therof in pharmaceutical compositions
#1088Orally disintegrating tablet containing bitterness-masking granules
#1089Process for the preparation of a solid, orally administrable pharmaceutical composition
#1090Pharmaceutical compositions and related methods of delivery
#1091Dry glassy composition comprising a bioactive material
#1092DRY POWDER FORMULATION OF AZOLE DERIVATIVE FOR INHALATION
#1093NOVEL AEROSOL FORMULATIONS OF ONDANSETRON AND USES THEREOF
#1094Abuse resistant forms of extended release morphine, method of use and method of making
#109517-hydroxyprogesterone ester containing oral compositions and related methods
#1096Stabilized granules containing glyceryl trinitrate
#1097Formulations for wound therapy
#1098Highly robust fast-disintegrating tablet and process for manufacturing the same
#1099Pharmaceutical compositions of fenofibrate
#1100PHARMACEUTICAL COMPOSITIONS OF TRIPTORELIN MICROSPHERES
#1101ORAL ADMINISTRABLE PHARMACEUTICAL COMPOSITION
#1102Biguanide compositions and methods of treating metabolic disorders
#1103Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
#1104Orthoester compound
#1105Modified release compositions of epalrestat or a derivative thereof and methods for using the same
#110617-hydroxyprogesterone ester containing oral compositions and related methods
#1107Method and system for producing high purity vancomycin hydrochloride
#1108Pharmaceutical composition
#1109Pazopanib formulation
#1110Pharmaceutical composition and administrations thereof
#1111Solid, orally administrable pharmaceutical composition
#1112Abuse resistant forms of extended release morphine, method of use and method of making
#1113Abuse resistant forms of extended release morphine, method of use and method of making
#1114Method for treating intestinal fibrosis
#1115Pharmaceutical compositions comprising entacapone, levodopa, and carbidopa
#1116Diaminooxidase-containing pharmaceutical compositions
#1117Taste-masked pharmaceutical compositions containing diclofenac
#1118Orally disintegrating tablets and methods of manufacture
#1119Formulations of 6-mercaptopurine
#1120Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use
#1121Process for stabilizing an adjuvant containing vaccine composition
#1122Compositions and methods for transplantation of colon microbiota
#1123Fast dissolving azaperone granulate formulation
#1124Freeze-dried aripiprazole formulation
#1125Granulated material mixture comprising two different granulated materials for artificial callus distraction
#1126Pulmonary delivery for levodopa
#1127Microparticle Formulations for Delivery to the Lower and Central Respiratory Tract and Methods of Manufacture
#1128Crystalline microspheres and the process of manufacturing the same
#1129Pharmaceutical formulations: salts of 8-[1-3,5-bis-(trifluoromethyl)phenyl)-ethoxy-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same
#1130Controlled agglomeration
#1131Dry powder vancomycin compositions and associated methods
#1132Modified release compositions comprising tacrolimus
#1133Use of stabilized granules containing glyceryl trinitrate for arteriogenesis
#1134Modified release compositions comprising tacrolimus
#1135Inhibitor of sodium-dependent glucose transport protein and preparation method therefor and use thereof
#1136Long-acting and controlled release formulations of 2-[(3-chlorophenyl) amino] phenylacetic acid
#1137Stable laquinimod preparations
#1138Pouch containing nicotine in free salt form
#1139Nitrogen-containing condensed heterocyclic compound
#1140Method of protecting biologically active substances against denaturation
#1141Dry powder formulations of particles that contain two or more active ingredients for treating obstructive or inflammatory airways diseases
#1142Method for treating inflammatory conditions with mucosally administered interleukin-2
#1143HIGH-CONCENTRATION MONOCLONAL ANTIBODY FORMULATIONS
#1144SOLID DOSAGE FORM COMPRISING PROTON PUMP INHIBITOR AND SUSPENSION MADE THEREOF
#1145Heparain-bulking agent compositions and methods thereof
#1146ORAL PHARMACEUTICAL COMPOSITIONS OF NEBIVOLOL AND PROCESS FOR THEIR PREPARATION
#1147Formulations and methods for lyophilization and lyophilates provided thereby
#1148Threo-DOPS controlled release formulation
#1149Solid pharmaceutical compositions of ppary modulator
#1150Stable corticosteroid nanoparticulate formulations and methods for the making and use thereof
#1151Organic amine salts of aminobenzoic acid derivatives and method for producing same
#1152Preparation for improving solubility of poorly soluble drug
#1153PHARMACEUTICAL ORAL DOSAGE FORMS COMPRISING DABIGATRAN ETEXILATE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS
#1154Co-processed tablet excipient composition its preparation and use
#1155Aildenafil citrate crystal form O, preparation method and use thereof
#1156Dispiropyrrolidine derivatives
#1157Pharmaceutical dosage forms comprising valganciclovir hydrochloride
#1158Composition comprising shellac and/or a salt thereof and sodium starch glycolate
#1159Antimicrobial agents
#1160Bile Acid Recycling Inhibitors for Treatment of Pediatric Cholestatic Liver Diseases
#1161Tolvaptan solid dispersion and its preparation method
#1162Stable solid pharmaceutical matrix compositions of sirolimus
#1163Devices, formulations, and methods for delivery of multiple beneficial agents
#1164Use of polyols to obtain stable polymorphous forms of rifaximin
#1165Stabilized pharmaceutical composition
#1166ORALLY DISPERSIBLE TABLET
#1167QUICK DISSOLVE NUTRITIONAL POWDER
#1168Methods of manufacturing viscous liquid pharmaceutical formulations
#1169COMPOSITION FOR THE PROPHYLAXIS OF CANDIDIASIS
#117017-hydroxyprogesterone ester-containing oral compositions and related methods
#1171PHARMACEUTICAL POWDER COMPOSITION FOR INHALATION
#1172Particulate comprising a calcium-containing compound and a sugar alcohol
#1173Pharmaceutical compositions comprising nilotinib or its salt
#1174Expression Modulator For Clock Gene Period
#1175ORAL PHARMACEUTICAL COMPOSITION COMPRISING FENOFIBRIC ACID AND AN ALKALIFYING AGENT
#1176Method for improving dissolution of anticoagulant agent
#1177MODIFIED AND IMMEDIATE RELEASE FORMULATIONS OF MEMANTINE
#1178Spray drying vancomycin
#1179Production method of solid preparation and the solid preparations produced by the method
#1180Dry glassy composition comprising a bioactive material
#1181TECHNOLOGY FOR PREVENTING ABUSE OF SOLID DOSAGE FORMS
#1182Solid pharmaceutical composition containing 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta (C)chromen-3-yl sulfamate and polymorphs thereof
#1183NEW PHARMACEUTICAL DOSAGE FORM FOR THE TREATMENT OF GASTRIC ACID-RELATED DISORDERS
#1184PROCESS FOR THE PRECIPITATION AND ISOLATION OF 6,6-DIMETHYL-3-AZA-BICYCLO [3.1.0] HEXANE-AMIDE COMPOUNDS BY CONTROLLED PRECIPITATION AND PHARMACEUTICAL FORMULATIONS CONTAINING SAME
#1185HIGHLY CONCENTRATED DRUG PARTICLES, FORMULATIONS, SUSPENSIONS AND USES THEREOF
#1186Pharmaceutical compositions comprising sigma receptor ligands
#1187Active ingredient delivery system
#1188Cellulose capsules and methods for making them
#1189DISPIROPYRROLIDINE DERIVATIVES
#1190NOVEL FORMULATION OF METAXALONE
#1191COACERVATION PROCESS
#1192Traditional Chinese drug comprising Danshen extracts and Sanqi extracts and use thereof
#1193FUSED HETEROCYCLIC COMPOUND HAVING AMINO GROUP
#1194SUBSTITUTED AMINOTHIAZINE DERIVATIVE
#1195AMINOTHIAZINE OR AMINOOXAZINE DERIVATIVE HAVING AMINO LINKER
#1196Preformulation for tabletting natural mixtures of conjugated estrogens
#1197Formulations of guanylate cyclase C agonists and methods of use
#1198DEXLANSOPRAZOLE COMPOSITIONS
#1199VACCINE FORMULATION OF MANNOSE COATED PEPTIDE PARTICLES
#1200Stable laquinimod preparations